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A pathway-focused complementary DNA microarray
and gene ontology analysis were used to investigate
gene expression profiles in the amygdala, hippocampus,
nucleus accumbens, prefrontal cortex (PFC) and ventral
tegmental area of C3H/HeJ and C57BL/6J mice receiving
nicotine in drinking water (100 mg/ml in 2% saccharin for
2 weeks). A balanced experimental design and rigorous
statistical analysis have led to the identification of 3.5–
22.1% and 4.1–14.3% of the 638 sequence-verified genes
as significantly modulated in the aforementioned brain
regions of the C3H/HeJ and C57BL/6J strains, respec-
tively. Comparisons of differential expression among
brain tissues showed that only a small number of genes
were altered in multiple brain regions, suggesting pres-
ence of a brain region-specific transcriptional response to
nicotine. Subsequent principal component analysis and
Expression Analysis Systematic Explorer analysis
showed significant enrichment of biological processes
both in C3H/HeJ and C57BL/6J mice, i.e. cell cycle/
proliferation, organogenesis and transmission of nerve
impulse. Finally, we verified the observed changes in
expression using real-time reverse transcriptase poly-
merase chain reaction for six representative genes in
the PFC region, providing an independent replication of
our microarray results. Together, this report represents
the first comprehensive gene expression profiling inves-
tigation of the changes caused by nicotine in brain
tissues of the two mouse strains known to exhibit
differential behavioral and physiological responses to
nicotine.
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Nicotine is the primary component in tobacco that maintains
habitual smoking by affecting various molecular and cellular
processes throughout the central nervous system (CNS)
(Wonnacott et al. 2005). By acting on a diverse set of nicotinic
acetylcholine receptors (nAChRs) within the CNS, nicotine
directly or indirectly modulates the signaling pathways of
a target neuron. Animal studies have indicated that nicotine,
like other drugs of abuse, stimulates dopamine secretion in
the outer shell of the nucleus accumbens (NA) (Pontieri et al.
1996; Robbins & Everitt 1999). Moreover, nicotine increases
the extracellular levels of the excitatory amino acids, gluta-
mine and aspartic acid in the ventral tegmental area (VTA)
through stimulation of nAChRs (Schilstrom et al. 2000).
Involvement of nicotine in both dopaminergic and glutamergic
neurotransmission also may contribute to its addictive poten-
tial and relation to neuropsychiatric disorders such as Alz-
heimer’s disease, Parkinsonism and schizophrenia
(Mihailescu & Drucker-Colin 2000).
Behavioral and pharmacologic studies indicate that C3H/
HeJ and C57BL/6 mice differ markedly in a number of
nicotine-related behaviors [for a review, see Crawley et al.
(1997)]. For example, C3H/HeJmice develop tolerance only at
high doses of chronically infused nicotine, whereas C57BL/6
animals do at much lower doses (Marks et al. 1991). A low
dose of nicotine increases the locomotor activity in C3H/HeJ
mice but depresses it in C57BL/6 mice (Marks et al. 1983).
C57BL/6 mice also consume significantly more nicotine than
do C3H/HeJ animals (Robinson et al. 1996). Moreover, mice
of the two strains differ in their clearance of nicotine and its
metabolites such as cotinine and nicotine N-oxide (Petersen
et al. 1984). For example, the half-life of nicotine N-oxide in
liver is greater in C57BL/6 than C3H/HeJ mice. Given such
obvious behavioral and pharmacological differences in the
response to chronic nicotine treatment between the two
strains, it would be interesting to determine which gene(s)
and biochemical pathway(s) are associated with these behav-
ioral characteristics.
Previous studies have shown that nicotine modulates the
expression of various genes in the CNS, including those
involved in catecholamine and neuropeptide synthesis and
transcriptional activation (Harlan & Garcia 1998; Li et al. 2000;
Pich et al. 1997). Recently, using focused complementary
DNA (cDNA) microarrays, we determined that the transcrip-
tional response to nicotine administration in rats was brain-
region and time dependent (Konu et al. 2001; Li et al. 2004).
Furthermore, we identified several functional groups of genes
both in vivo and in vitro as likely targets of nicotine addiction,
such as those belonging to the phosphatidylinositol (PI) and
growth factor-signaling pathways and the ubiquitin family
(Konu et al. 2001, 2004; Li et al. 2002, 2004). The primary
purpose of the present study was to identify and characterize
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the gene expression profiles in the amygdala, hippocampus,
NA, prefrontal cortex (PFC), and VTA of the C3H/HeJ and
C57BL/6J mouse strains in response to chronic oral nicotine
administration using a pathway-focused cDNA microarray
developed recently in this laboratory.
Materials and methods
Animals and brain tissue collection
Two-month-old male C3H/HeJ and C56BL/6J mice purchased from
the Jackson Laboratory (Bar Harbor, ME, USA) were housed in wire-
bottom cages in the 12/12 h light/dark cycle and were allowed food
and water ad libitum. Animal received either nicotine tartrate (pH 7.0;
Sigma, St Louis, MO, USA) through their drinking water at a dose of
100 mg/ml as free base in 2% saccharin solution (treatment group) or
2% saccharin alone (control group) for 14 days (Sparks & Pauly
1999). All experimental protocols were approved by the Institutional
Animal Use Committee. Ten animals from each strain (five for the
control and five for the nicotine-treated group) were included in the
microarray and the quantitative RT–PCR verification experiments,
separately.
After 2 weeks of nicotine treatment, mice were killed with a lethal
overdose of sodium pentobarbital, and the brains were dissected out
immediately after decapitation. After 2-mm brain slices were cut
using a Stoelting tissue slicer (Stoelting, Chicago, IL, USA), bilateral
punches were excised from the amygdala, anterior area of the
hippocampus, NA, PFC and VTA using a bilateral 2.0-mm-diameter
brain punch tissue set (myNeuroLab.com, St Louis, MO, USA)
according to the co-ordinates of Paxinos & Franklin (2001) in a dish
containing ice-cold saline. All the tissues were stored at 808C until
RNA isolation.
RNA isolation and reverse transcription, cDNA probe
labeling, hybridization and image analysis
Total RNA was isolated separately from each brain region of each
mouse using Trizol reagent (Invitrogen, Carlsbad, CA, USA) and was
amplified as described previously for adequate cDNA probe labeling
(Gutala et al. 2004; Konu et al. 2004). The detailed procedures for
cDNA probe labeling and hybridization were the same as reported
previously (Gutala et al. 2004; Li et al. 2004). Briefly, 2 mg of amplified
RNA was added to a cocktail consisting of 4 ml of 5 RT buffer, 2 ml of
0.1 M dithiothreitol (DTT), 5 ml of 10 mM dNTPs mixture, 1 ml of RNasin,
4 mg of Cy3-labeled random nanomer (Tri-Link Technology, San Diego,
CA, USA) and 2 ml of Superscript II reverse transcriptase (Invitrogen).
The RT reaction was carried out at 428C for 1.5 h, and the mixture was
incubated at 858C for 5 min to inactivate the enzyme. The purified
cDNA probes were mixed with hybridization solution consisting of
25% formamide, 3 saline sodium citrate (SSC) and 0.1% sodium
dodecyl sulphate (SDS). A homeostatic pathway-focused microarray
consisting of 638 sequence-verified genes was used (Konu et al.
2004). The slides were hybridized for approximately 16 h at 428C and
washed in 1 SSC and 0.1% SDS at 428C for 10 min followed by
washing in 0.1 SSC, 0.2% SDS and 0.1 SSC for 5 min each at room
temperature. Scanning was performed using the GenePix 4000B
scanner and the intensities were quantified with GenePix 4.1 soft-
ware (Axon Instruments, Union City, CA, USA).
Data normalization and statistical analysis
For each slide, the logarithmically transformed (on base 2) background-
subtracted median intensity was used for further analysis. As in
previous studies, the two replicates of each probe on the micro-
arrays were treated as independent measurements (Konu et al.
2004; Li et al. 2004). The duplicate spots pairs with relative large
intensity difference as indicated by an iteratively reweighted least-
square algorithm (robustfit function; Matlab; The Mathworks,
Natick, MA, USA) were considered unreliable and excluded from
further analysis (Konu et al. 2004). Data from each brain region of
either strain were normalized using a cyclic lowess (locally weighted
linear regression) to make replicates/slides comparable (Edwards
2003). In this procedure, a subset of normalization probes that
appeared to be least regulated across each replicate pair were
identified to construct a normalizing curve with parameters, P ¼
0.015 and l ¼ 15. Normalized measurements of each gene within an
experimental group were subjected to an outlier-detection proce-
dure (Li et al. 2004) such that a gene was removed from further
analysis if there were fewer than six valid measurements in either
the control or the nicotine treatment group after removal of the
outliers. Furthermore, the normalized data of only those genes with
fold changes <0.85 or >1.15 between the nicotine-treated and
control samples for each region were subjected to Student’s t-test
to detect the genes significantly regulated by nicotine (P < 0.05).
Principal component analysis (PCA) is a multivariate statistical
method used to exploit essential factors to define a pattern in a data
set by reducing the effective dimensionality of the data set (Crescenzi &
Giuliani 2001). Specifically, PCA was implemented in the following
way in this study: for each mouse strain, the normalized measure-
ments were extracted for all the five brain regions for the genes
differentially expressed in one or more regions. To reduce variation
among the data of control samples, for each brain region, we
averaged the normalized expression of controls for each gene and
subtracted the mean from the normalized expression values of the
nicotine-treated group. Then, the adjusted data from the five brain
regions were merged and subjected to PCA with genes as variables
and measurements as observations. The PCA analysis was per-
formed using Matlab.
Categorization of biological process using Gene
Ontology
Procedure of Expression Analysis Systematic Explorer (EASE)
(Hosack et al. 2003) was used to assign the significantly differentially
expressed genes to ‘‘GO: Biological Process’’ categories of the Gene
Ontology Consortium (www.geneontology.org). For genes whose
biological process categories were not available in the EASE data
sets, SOURCE (http://source.stanford.edu) also was searched to
retrieve the relevant information. The categories with very few genes
were merged with related categories. EASE analysis was carried out
to test significance of enrichment for the co-expressed gene sets
within each biological process category; an EASE score of 0.15 or less
was considered significant (Blalock et al. 2004).
Validation of microarray results by quantitative
real-time RT–PCR
The microarray results for six representative genes were validated
using quantitative real-time RT–PCR (qRT–PCR) on RNA samples
extracted from an independent animal experiment as previously
described (Gutala et al. 2004; Konu et al. 2004). Briefly, PCR was
carried out in 25 ml containing 1 ml of 12.5 mM dNTPs, 1 PCR buffer
and 2.5 U of TaqMan or SYBER green on the ABI 7000 sequence
detection system (Applied Biosystems, Foster City, CA, USA). A
duplicate was run for each sample, along with a no-template control.
18 S ribosomal RNA was used as an internal control to normalize the
expression levels of a target gene. The qRT–PCR data were analyzed
using a comparative Ct method (Winer et al. 1999). Primer sequences
were selected according to the cDNA sequence printed on the
microarray for Homer homolog 2 (homer2): 50-AGGGCAGGGATGTT-
TAGATCTTC-3 0 (forward) and 50-CCCCATCCCCGGTTCATA-30
(reverse) and amyloid beta A4 precursor protein binding, family B,
member 2 (Apbb2): 50- TCGGCCACATCGCATTCT-30 (forward) and
50- GGTATGCAGGCGATCTTTGTTC-30 (reverse). For the other four
genes, amyloid beta (A4) precursor protein (App), amyloid beta (A4)
precursor-like protein 2 (Aplp2), inhibitor of kappa light polypeptide gene
enhancer in B cells, kinase epsilon (Ikbke) and glutamate receptor, iono-
tropic, alpha-amino-3-hydroxy-5-methyl-4-isoxaolpropionate (AMPA 2)
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(Gria2), the primers and TaqMan probes were purchased from ABI,
and no sequence information was provided by the vendor.
Results
Identification of genes regulated by chronic nicotine
treatment
The microarray analysis results may include a large number
of false positives arising from multiple comparisons. To
identify significantly regulated genes while minimizing mul-
tiple comparison error, one may choose to use a more
stringent P value in identification of differentially expressed
genes with the tradeoff of producing more false negatives.
Another way is to filter the microarray data in reducing the
number of tests need to be performed because for a given
P value, the number of expected false positives is pro-
portional to the total number of comparisons (Blalock et al.
2004, 2005).
Previous work from this and other laboratories has indi-
cated that the changes in expression level of modulated
genes by nicotine were subtle both in vivo and in vitro
(Dunckley & Lukas, 2003; Konu et al. 2001, 2004; Li et al.
2004); thus might present potential problems in the down-
stream validation experiments. Given these considerations,
use of a fold difference of 15% between the treatment and
control groups as a cutting point helped keep a balance
between the number of significantly regulated genes identi-
fied and the false discovery rate (FDR) for all the brain regions
of the two strains. In our case, the expected false positives
was calculated as the product of the number of genes tested
and P, while the total number of positives was the number of
genes with fold change difference 15% and P < 0.05. By
doing so, we greatly reduced the number of genes to be
tested for each brain region of both strains. For C3H/HeJ, 44,
40, 102, 288 and 198 genes and for C57BL/6J, 164, 86, 219,
55 and 34 genes were kept for statistical testing for amyg-
dala, hippocampus, NA, PFC and VTA, respectively.
The number of differentially expressed genes varied greatly
among the five brain regions of either strain (Tables 1, S1 and
S2). For example, nicotine treatment of the C3H/HeJ mouse
resulted in 22, 32, 94, 111 and 141 differentially expressed
genes in the amygdala, hippocampus, NA, PFC and VTA,
respectively, representing 3.5–22.1% of the 638 genes, and
the FDRs were in the range of 0.05–0.13. There were also
more upregulated genes than downregulated in four of the
five regions with the exception being the hippocampus.
However, in the C57BL/6J mice, differentially expressed
gene numbers were 46, 46, 91, 30 and 24 in the amygdala,
hippocampus, NA, PFC and VTA, respectively (Table 1),
representing 4.1–14.3% of the 638 genes with FDRs ranging
from 0.09 to 0.18. In this case, more downregulated than
upregulated genes in the VTA of C57BL/6J mice were
observed.
For the C3H/HeJ strain, a total of 312 genes were signif-
icantly modulated in the presence of nicotine in at least one
brain region, and of these 77 were modulated in two or more
regions. However, only seven of them (i.e. Adrald, Avp,
Loc245960, Pbx3, Pcp4, Pla2g4a and Pou5f1; Table S3) were
differentially modulated in three regions. For the C57BL/6J
strain, expressions of 190 genes were changed significantly
in at least one brain region, and 28 of themwere modulated in
at least two regions. However, only 4 of these 28 (i.e. Gria2,
Gtse1, Nr1d1 and Slc6a4; Table S4) were common in three or
more regions.
Table 2 lists the genes significantly regulated in each brain
region of both mouse strains. In the amygdala, Usp2, Il15,
Gsk3b and Kcr1messenger RNA (mRNA) expression showed
a striking inverse direction in their modulation by nicotine
between the two strains, while Pcp4, Psmb2, Rpl30 and
Tcfeb in the hippocampus were modulated in the same
direction. Among the 18 co-expressed genes in the NA, most
were upregulated in both strains except that Hap1, Celsr3,
Rock1, Accn1, Atp6k and Kcr1 showed an inverse correlation.
In the PFC, only the transcription of Tcf21 was common to
both strains. In VTA, some of the co-expressed genes
exhibited inverse correlations (Sst, Syt5 and Slc6a4), whereas
S100a6 and Tnf mRNAs were upregulated in both strains.
Consistent with the inherent biological variations between
the C3H/HeJ and C57BL/6J strains, nicotine treatment pro-
duced substantial differences in gene expression patterns in
different brain regions (Tables S1 and S2). Among these,
several genes involved in neuronal function and development
are noteworthy. For example, glycogen synthase kinase-3 beta







Amygdala 16[, 6Y; 3.5 0.10 23[, 23Y; 7.2 0.18
Hippocampus 16[, 16Y; 5.0 0.06 39[, 7Y; 7.4 0.09
NA 69[, 25Y; 14.7 0.05 68[, 23Y; 14.3 0.12
PFC 80[, 31Y; 17.4 0.13 16[, 14Y; 4.7 0.09
VTA 122[, 19Y; 22.1 0.07 9[, 15Y; 4.1 0.07
FDR, false discovery rate.
[ and Y, upregulation or downregulation compared with controls.
*The percentages are based on 638 sequence-verified genes on the chips.
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(Gsk3b) was upregulated by 18% (P ¼ 0.008) in the amygdala
of C3H/HeJmice and downregulated by 17% (P¼ 0.024) in the
same brain region of the C57BL/6J strain. Potassium channel,
subfamily K, member 1 (Kcnk1), an inwardly rectifying Kþ
channel, was downregulated by 16% (P ¼ 0.005) and upregu-
lated by 23% (P ¼ 0.049) in the hippocampus of the two
strains, respectively. The expression of neuron-specific protein,
Purkinje cell protein 19 (PEP-19) (PCP4) was downregulated
by 33% (P< 0.001) and 28% (P¼ 0.01) in the hippocampus of
the C3H/HeJ and C57BL/6J mice, respectively.
Table 2: A list of coregulated genes in both C3H/HeJ and C57BL/6J strains within each brain region
Region Gene symbol Gene name
Fold Change
C3H/HeJ C57BL/6
Amyg Protein modification and degradation
Usp2 Ubiquitin-specific protease 2 0.83 1.24*
Signaling transduction
Il15 Interleukin 15 1.17 0.79
Gsk3b Glycogen synthase kinase- 3 beta 1.18 0.83
Transport
Kcr1 Potassium channel regulator 1 1.20* 0.60
HP Neuronal structure and transmission
Pcp4 Neuron-specific protein PEP-19 (Purkinje cell protein 4) 0.67* 0.72
Protein modification and degradation
Psmb2 Proteasome (prosome, macropain) beta 2 subunit 1.17 1.24
Protein synthesis
Rpl30 Ribosomal protein L30 1.16 1.21
Transcription factors
Tcfeb Transcription factor EB 1.22 1.18*
Transport
Kcnk1 Potassium channel, subfamily K, member 1 0.84 1.23
NA Cell division
Ask Activator of S phase kinase 1.16 1.31
Ccnc Cyclin C 1.16 1.42*
Ccng Cyclin G 1.20 1.33*
Gspt1 G1 to phase transition 1 1.26 1.65*
H1f0 H1 histone family, member 0 1.16 1.67*
Hist4 Histone 4 protein 1.16 1.26
Cell structure
Cugbp2 CUG triplet repeat, RNA-binding protein 2 1.23 1.77*
Neuronal structure and transmission
Hap1 Huntingtin-associated protein 0.80 1.39*
Nrcam Neuron-glia-CAM-related cell adhesion molecule 1.23 1.44*
Signaling transduction
Celsr3 Cadherin EGF LAG seven-pass G-type receptor 3 0.82 1.39*
Dnclc1 Dynein, cytoplasmic, light chain 1 1.19 1.53*
Fgf2 Fibroblast growth factor 2 1.16 1.40
Rock1 Rho-associated kinase beta subunit 0.78 1.34
Transcription factors
Pbx3 Pre-B-cell leukemia transcription factor 3 1.19 1.25
Transport
Accn1 Amiloride-sensitive cation channel 1, neuronal (degenerin) 0.73* 1.51
Atp6k Vacuolar proton-adenosine triphosphatase subunit M9.2 0.84 1.31
Kcr1 Potassium channel regulator 1 1.30* 0.68
Unclassified
Mosg Mosg protein 1.16 1.26
PFC Transcription factor
Tcf21 Transcription factor 21 1.38 1.17
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Determination of biological processes associated
with nicotine treatment in different brain regions
In addition to determining differentially expressed genes in
each brain region of both mouse strains, the overrepresented
categories of biological processes within each brain region
were analyzed using EASE (Table 3) and representative
genes are shown in Tables S5 and S6.
Amygdala
For the C3H/HeJ mice, no overrepresented biological process
was detected among either downregulated or upregulated
genes, whereas for the C57BL/6J mice, the intracellular
signaling cascade process was overrepresented among the
upregulated genes (e.g. Mapk8ip3, Map2k1, Rab11a and
Ab11; Table S5). In addition, the biological process of cell
organization/biogenesis was overrepresented among the
downregulated genes.
Hippocampus
No overrepresented biological process was detected for
the C3H/HeJ strain, while the process related to ubiquitin-
dependent protein catabolism, comprising multiple ubiquitin-
related genes (e.g. Uchl5, Ube2d2, Ubl1 and Usp5) and
proteasome subunits (e.g. Psmb2, Psmb4, Psmb5 and
Psmb6) was overrepresented in the upregulated genes of
C57BL/6J mice (Table S5); and the process related to cellular
metabolism and signal transduction were overrepresented in
the downregulated genes.
Nucleus accumbens
Although more than 100 significantly regulated genes were
detected for this region, only the process of cell cycle/
proliferation was overrepresented among the upregulated
genes in C3H/HeJ mice (Table S6). Among the four biological
processes overrepresented in this region of C57BL/6J mice
(Table 3), the categories of cell cycle/proliferation and trans-
mission of nerve impulse were of particular interest. Cell
cycle/proliferation was overrepresented in both C3H/HeJ and
C57BL/6J mice, and several genes were modulated in both
strains (i.e. Ask, Fgf2, Ccng, Ccnc and Gspt1). For the
transmission of nerve impulse category, the genes found to
be altered in C57BL/6J mice (e.g. Gabrd, Gria2 and Grik2)
were different from those for C3H/HeJ mice.
Prefrontal cortex
In contrast to the NA, the cell cycle/proliferation category was
downregulated in the PFC of C3H/HeJ mice. Inspection of the
list showed several common genes in the PFC and NA (e.g.
Abl1, Ccnh, Cdc25c andMap2k7). Organogenesis was down-
regulated, while categories of intracellular signaling cascade
and proteolysis/peptidolysis were upregulated in this brain
region. For the C57BL/6J mice, transmission of nerve im-
pulses was overrepresented among the upregulated genes,
with two genes (Gria2 and Mag) overlapping with the list of
the same category in the NA.
Ventral tegmental area
Three biological process categories, i.e. cell-surface recep-
tor-linked signal transduction, intracellular signaling cas-
cade and transmission of nerve impulses, were
overrepresented among the upregulated genes in C3H/
HeJ mice. For the category of cell-surface receptor-linked
signal transduction, most affected genes were part of
the integrin-mediated signaling (Cib1, Itga7 and Itgb7), G-
protein-coupled receptor protein signaling (e.g. Rgs2,
Rgs14, Gnb2, Adra1b and Adra1d), and transmembrane
receptor protein tyrosine kinase signaling (Kdr, Egf, Ltbp1
and Bdkrb2) pathways. For the intracellular signaling cas-
cade, most genes belonged to the protein kinase cascade
(e.g. Mapk13, Map4k4, Rps6ka2 and Mapk9) and small
guanosine triphosphatase-mediated signal transduction
(Rheb, Rasa3, Rhob, Arls and Rrad). In the transmission of
nerve impulses category, various neurotransmitters were
included (Table S6). Interestingly, this category was over-
represented among the downregulated genes of C57BL/6J
mice (Table S5).
Table 2: Continued




Neuronal structure and transmission
Chrna4 Nicotinic acetylcholine receptor a 4 1.50* 0.77*
Grik2 Glutamate receptor, ionotropic, kainate 2 1.24 0.80*
Signaling transduction
Adra1d Alpha-1A-adrenergic receptor 1.46* 1.15
S100a6 S100 calcium binding protein A6 1.63 1.26*
Sst Somatostatin 1.60* 0.81
Syt5 Synaptotagmin 5 2.39* 0.78
Tnf Tumor necrosis factor, alpha (cachetin) 2.89* 1.17
Transport
Slc6a4 Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 1.46* 0.78
All genes given in the table are at 0.05 significant level except for those genes marked with *, which indicates a significant level of 0.01.
CAM, cell adhesion molecule; CUG, genetic codon CUG; EGF, epidermal growth factor; LAG, laminin A G-type.
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Determination of unique and common biological
processes in C3H/HeJ and C57BL/6J mice
As described earlier, we identified 312 differentially ex-
pressed genes in C3H/HeJ and 190 in C57BL/6J mice. PCA
using genes as variables allowed for projection of the C3H/
HeJ data set (312 variables  50 observations) and the
C57BL/6J data set (190  50) onto new multidimentional
spaces (Fig. 1a,b, respectively). The sudden drop in the
eigenvalue contributions with the increasing number of
components suggested use of a five-component model for
Table 3: Categories of biological processes overrepresented in each brain region of C3H/HeJ and C57BL/6J
Brain region Biological process category
Downregulated Upregulated
C3H/HeJ C57BL/6 C3H/HeJ C57BL/6
Amyg
Cell organization and biogenesis (29)* NS 4/23† (0.0766‡) NS NS
Intracellular signaling cascade (60) NS NS NS 6/23 (0.0468)
HP Ubiquitin-dependent protein catabolism (35) NS NS NS 12/39 (0.0001)
NA
Cellular metabolism (53) NS 6/23 (0.0315) NS NS
Cell cycle/proliferation (99) NS NS 16/72 (0.1332) 23/69 (0.0002)
Organogenesis (35) NS NS NS 9/69 (0.0277)
Signal transduction (31) NS 4/23 (0.0900) NS NS
Transmission of nerve impulse (31) NS NS NS 9/69 (0.0133)
Vesicle-mediated transport (10) NS 3/23 (0.0450) NS NS
PFC
Cell cycle/proliferation (99) 10/31 (0.0346) NS NS NS
Intracellular signaling cascade (60) NS NS 12/81 (0.1113) NS
Ion transport (53) NS NS NS 5/16 (0.0313)
Organogenesis (35) 5/31 (0.0809) NS NS NS
Proteolysis and peptidolysis (18) NS NS 7/81 (0.0192) NS




NS NS 23/126 (0.0473) NS
Intracellular signaling cascade (60) NS NS 19/126 (0.0324) NS
Ion transport (53) NS 7/18 (0.0017) NS NS
Neurotransmitter transport (4) NS 2/18 (0.1048) NS NS
Transmission of nerve impulse (31) NS 6/18 (0.0002) 14/126 (0.0035) NS
NS, not significant.
*Number in parenthesis under the column of ‘Biological process categories’ are the number of genes printed on the chips that are belonging to
corresponding categories of Gene Ontology: Biological processes.
†Number of downregulated or upregulated genes and the number of regulated genes falling in corresponding biological process categories.
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Figure 1: Number of component vs. contributed variance of each component from PCA on differentially expressed genes for
the data sets of C3H/HeJ (a) and C57BL/6J (b) mice. For both strains, first 22 components contributing more than 50% of total
variance are shown.
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both mouse strains, explaining, respectively, 72% and 67%
of the total variability observed in the 312 and 190 gene
expression data for C3H/HeJ and C57BL/6J mice, respec-
tively. For both mouse strains, 30 genes with the highest
absolute loadings were selected for each of the five PCA
components. To determine whether the selected 30 genes
were involved in certain biological procedures or just ran-
domly distributed, EASE analysis was performed. For C3H/
HeJ, cell-surface receptor-linked signal transduction and
intracellular signaling cascade biological processes were
overrepresented in the first principal component, while cell
cycle/cell proliferation, organogenesis, transmission of nerve
impulses and cell organization/biogenesis biological pro-
cesses were overrepresented in the second principal com-
ponent. No overrepresented category was detected for the
remaining three components. For C57BL/6J mice, the biolog-
ical processes of cell cycle/cell proliferation and organogen-
esis were overrepresented for the first principal component
and the biological processes of transmission of nerve im-
pulses and ubiquitin-dependent protein catabolism for the
second and third principal component, respectively. No over-
represented category was detected for the fourth and fifth
component. Furthermore, we found that the EASE scores of
these categories were stable when 10, 20, 40, 50 and 60
genes with the highest absolute loadings were selected
(Fig. 2). This indicates that the biological processes identified
here might represent the major contribution in the response
to chronic nicotine treatment in the two mouse strains at the
whole brain level.
Validation of microarray results by qRT–PCR
The mRNA expression levels of six genes, i.e. App, Apbb2,
Aplp2, Homer2, Gria2 and Ikbke, were validated by qRT–PCR
analyses in the PFC region of both strains (Figure S1). These
genes were selected because they have been shown to be
involved in important biological processes and signaling path-
ways related to substance abuse (Asztely & Gustafsson 1996;
Guenette et al. 1996; Kravchenko et al. 2003; Soloviev et al.
2000) and are regulated by nicotine (Adriani et al. 2004; Kane
et al. 2005; Mochida-Nishimura et al. 2001; Tsurutani et al.
2005; Wang et al. 2007).
For C3H/HeJ animals, microarray analysis showed that two
of the six genes were significantly regulated in PFC (Apbb2:
fold change 1.43, P ¼ 0.045; Ikbke: fold change 1.36, P ¼
0.034), which were consistent with the result obtained from
real-time RT–PCR. Microarray analysis also showed two other
genes from the amyloid precursor protein (APP) family were
modulated (APP: fold change 0.72, P ¼ 0.056; Aplp2: fold
change 1.17, P ¼ 0.073), which were also confirmed by the
real-time RT–PCR analysis. For genes Homer2 and Gria2,
both microarray and real-time RT–PCR analysis showed an
insignificant regulation by nicotine in PFC. For C57BL/6J,
microarray analysis showed that the expression of four
genes, i.e. APP (fold change 1.27, P ¼ 0.013), Ikbke (fold
change 1.11, P ¼ 0.019), homer2 (fold change 0.73, P ¼
0.042), Grai2 (fold change 1.22, P < 0.001), were significantly
modulated, consistent with the results from real-time RT–
PCR. Microarray analysis showed that Aplp2 (fold change
1.06, P ¼ 0.463) and Apbb2 (fold change 1.15, P ¼ 0.140)
showed a trend of upregulation although non-significant.
Real-time RT–PCR, however, indicated a larger magnitude
of upregulation for both genes (Aplp2: fold change 1.16, P ¼
0.082; Apbb2: fold change 1.78, P < 0.001). A comparison of
the fold changes of the six genes detected by microarray and
real-time RT–PCR showed a correlation coefficient of 0.92
(P ¼ 0.009) for C3H/HeJ and 0.82 (P ¼ 0.046) for C57BL/6J,
further indicating our microarray results were reproducible
and reliable.
Discussion
In this study, using cDNA microarrays, we have identified
a catalogue of brain region-specific genes that might contrib-
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Figure 2: Overrepresented categories of biological processes identified in principal components of PCA. For each strain, the first
five principal components were selected, and the 30 geneswith the highest absolute loadings were subjected to EASE analysis to detect
the overrepresented biological processes. EASE scores at 20, 40, 50 and 60 genes with the highest absolute loadings for each principal
component were plotted.
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response to chronic oral nicotine treatment. Our study also
helped to define significant changes in gene expression
patterns that exhibit regional diversity in the brains of C3H/
HeJ and C57BL/6J mice in response to nicotine. The number
of differentially expressed genes was found to differ sub-
stantially between brain regions within and between the two
strains (Tables 1, S1 and S2). For instance, PFC and VTA
were the two regions in C3H/HeJ mice having the highest
number of modulated genes, while the same two regions
exhibited relatively fewer transcriptional modulations in
C57BL/6J mice. In addition, we found that only a handful
of genes were significantly altered in more than two brain
regions, suggesting a high degree of brain region specificity
in the transcriptional response to nicotine. Comparisons
among differentially expressed genes in multiple brain
regions also showed that the same set of genes could be
modulated inversely in different regions. Together, the
complex gene expression architecture identified in this
analysis clearly shows the regional diversity and complexity
of the brain’s response to nicotine.
The biological processes associated with the differentially
expressed genes can provide clues to the mechanisms by
which each brain region of a specific strain responds to
nicotine. Most of the overrepresented biological processes
were observed in the NA, PFC and VTA, which play a central
role in co-ordinating the rewarding effects of nicotine (Kalivas &
Nakamura 1999; Robbins & Everitt 1999). The PCA and EASE
analyses were used to show the major biological processes
responsible for the variation across brain regions. More
categories were identified for C3H/HeJ mice than for
C57BL/6J mice, while many categories identified in each
strain were overrepresented in at least one brain region. Of
the six categories of biological process identified in C3H/HeJ
mice, three (i.e. cell cycle/proliferation, organogenesis and
transmission of nerve impulses) were also identified in
C57BL/6J mice, suggesting that these two strains might
exhibit similar functional responses to nicotine treatment.
Nicotine exerts stimulatory or inhibitory effects on the cell
cycle and proliferation under different conditions (Chu et al.
2005; Hakki et al. 2000; Trombino et al. 2004). In particular,
nicotine increases cell proliferation rates in dividing cells by
modulating the Ras-induced expression of cyclin D1 (Chu
et al. 2005). Modulation of cell cycle-related genes by nicotine
in postmitotic neuronal populations is likely to lead to a differ-
ent cellular response than it produces in mitotic cells
(Schmetsdorf et al. 2005). Our results indicate that nicotine
imposes variable influences on the cell cycle and proliferation
in different brain regions. For example, the cell cycle/
proliferation process was upregulated in the NA of both
C3H/HeJ and C57BL/6J mice, whereas this process was
downregulated in the PFC of C3H/HeJ but not of C57BL/6J
mice. It is likely that cyclins and associated cdks also might
have roles other than proliferation in the NA such as neuronal
survival and synaptic plasticity. In the PFC of C3H/HeJ mice,
the organogenesis category also was downregulated by
nicotine. The same regulation patterns of cell cycle/prolifera-
tion and organogenesis can be attributed, in part, to the fact
that some genes may be involved in both biological pro-
cesses, although another reason may be that the two pro-
cesses are coupled and thus change in similar ways.
The process of transmission of nerve impulses includes
a series of receptors that are critical to the biological response
to nicotine. The transmission of nerve impulses category was
overrepresented among the upregulated genes in the VTA of
C3H/HeJ mice; but, interestingly, in C57BL/6J mice, it was
downregulated in the VTA, while being upregulated in the NA
and PFC (Table S6). This finding implies that the mechanism
by which the two strains respond to nicotine is different.
Nicotine induced upregulation of different cell-surface-based
receptors (i.e. Grik2 and Syt5) in the VTA of C3H/HeJ animals,
while suppressed the expression of these genes (i.e., Grik2
and Syt5) in this region of C57BL/6J, indicating the differential
effects of nicotine treatment on various intracellular signaling
pathways in this region. This coordinated differential expres-
sion pattern suggests that these two strains, exhibiting highly
divergent nicotine-induced behavioral and physiological char-
acteristics, also differ in their nicotine-induced receptor
activation, desensitization and inactivation profiles (Laviolette &
van der Kooy 2004; Pidoplichko et al. 2004).
The expressional profile especially in the VTA region of
C3H/HeJ, but not of C57BL/6J, mice was characterized by
overrepresentation of genes that belong to the intracellular
signaling and signal transduction/receptor categories, partic-
ularly to mitogen-activated protein kinase cascade (MAPK)
signaling. Previous studies (Konu et al. 2004; Nakatani et al.
2004) collectively suggest that nicotine exerts its mitogenic
and survival-related actions via MAPK. Our findings in this
study further support strain-specific MAPK activation by
nicotine, as mRNA expression of several genes with essential
roles in the production of IP3 and downstream activation of
complexes such as PI3K/AKT and others also were upregu-
lated by nicotine in both the PFC and VTA of C3H/HeJ, but not
in those of C57BL/6J, mice. These results strongly suggest
that the PI pathway-driven MAPK signaling cascade might be
relatively more active in C3H/HeJ than in C57BL/6J mice.
Nicotine can alter the expression of various genes involved in
multiple signal transduction pathways (Konu et al. 2001, 2004;
Li et al. 2004). The biological process of ubiquitin-dependent
protein catabolism was upregulated in the hippocampus of
C57BL/6J mice. Although it was not overrepresented in the
hippocampus of C3H/HeJ mice, several genes from this
pathway were also upregulated (e.g. Psmb2 and Uchl1). The
hippocampus is involved in learning and memory, and nicotine
can influence the synapticplasticity in this brain region (Balfour&
Ridley 2000; Ji et al. 2001). Our results suggest that the
physiological influence of nicotine on the hippocampus might
be through upregulation of the ubiquitin–proteasome pathway.
These findings are consistent with the results of our previous
study on nicotine-treated rats (Kane et al. 2004) and ethanol-
treated cortex neurons (Gutala et al. 2004).
It should be noted that, among the genes identified by
microarray analysis in the current work, only a limited number
of transcripts received independent confirmation using real-
time RT–PCR. As pointed previously (Blalock et al. 2005; Kane
et al. 2004; Li et al. 2004; Mirnics et al. 2001), the major
advantage of microarray analysis is not only limited to the
identification of single genes, but also its ability to provide
a more comprehensive perspective about the regulation
of biochemical pathways or functionally related genes. As
the current work aimed mainly at detecting the biological
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pathways and processes involved in the response to chronic
nicotine treatment in the two mouse strains, identifying the
overrepresentation of multiple genes related to certain bio-
logical pathways or processes not only provides insights
regarding the role of the pathways, but also adds confidence
to the reliability of the genes identified in the study. However,
it is still advisable to take caution when referring to regulation
of a specific gene.
In summary, by using a systematic approach to compare
the gene expression profiles in five brain regions pertinent to
nicotine’s actions in C3H/HeJ and C57BL/6J mice, we
showed that the expression patterns modulated by nicotine
are strain and region specific. In both mouse strains, various
biological processes regulated by nicotine were identified.
Some of these pathways, e.g. cell cycle/proliferation and
transmission of nerve impulses, were commonly regulated in
the two strains, indicating that even with the diversity of
genes modulated by nicotine, the effects on underlying
biological processes appeared similar in certain brain regions.
However, we identified several biological process categories
with respect to specific signaling pathways (MAPK and
ubiquitin–proteasome) whose changes were unique to each
mouse strain. It is our hope that this type of approach will help
us to understand the interplay between genes and pathways
connected to complex behaviors such as nicotine addiction.
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